BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 11756961)

  • 1. Livedo (livedoid) vasculitis and the factor V Leiden mutation: additional evidence for abnormal coagulation.
    Calamia KT; Balabanova M; Perniciaro C; Walsh JS
    J Am Acad Dermatol; 2002 Jan; 46(1):133-7. PubMed ID: 11756961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Livedoid vasculopathy and its association with factor V Leiden mutation.
    Yong AA; Tan AW; Giam YC; Tang MB
    Singapore Med J; 2012 Dec; 53(12):e258-60. PubMed ID: 23268168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A case of livedoid vasculopathy associated with factor V Leiden mutation: successful treatment with oral warfarin.
    Kavala M; Kocaturk E; Zindanci I; Turkoglu Z; Altintas S
    J Dermatolog Treat; 2008; 19(2):121-3. PubMed ID: 18484430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Livedoid vasculopathy in a patient with factor V mutation (Leiden).
    Biedermann T; Flaig MJ; Sander CA
    J Cutan Pathol; 2000 Sep; 27(8):410-2. PubMed ID: 10955688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Livedoid vasculopathy with heterozygous factor V Leiden mutation and sticky platelet syndrome].
    Lewerenz V; Burchardt T; Büchau A; Ruzicka T; Megahed M
    Hautarzt; 2004 Apr; 55(4):379-81. PubMed ID: 15021932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Livedoid vasculopathy.
    Chang D; Patel RM
    Cutis; 2012 Oct; 90(4):179, 181-2. PubMed ID: 23259203
    [No Abstract]   [Full Text] [Related]  

  • 7. Ulcerations caused by livedoid vasculopathy associated with a prothrombotic state: Response to warfarin.
    Davis MD; Wysokinski WE
    J Am Acad Dermatol; 2008 Mar; 58(3):512-5. PubMed ID: 18280355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Livedoid vasculopathy associated with plasminogen activator inhibitor-1 promoter homozygosity (4G/4G) treated successfully with tissue plasminogen activator.
    Deng A; Gocke CD; Hess J; Heyman M; Paltiel M; Gaspari A
    Arch Dermatol; 2006 Nov; 142(11):1466-9. PubMed ID: 17116837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Livedoid vasculopathy: what it is and how the patient should be evaluated and treated.
    Callen JP
    Arch Dermatol; 2006 Nov; 142(11):1481-2. PubMed ID: 17116840
    [No Abstract]   [Full Text] [Related]  

  • 10. [Vasculitis and vasculopathy].
    Marković A
    Acta Med Croatica; 2012 Oct; 66 Suppl 1():19-24. PubMed ID: 23193816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Livedoid vasculopathy: further evidence for procoagulant pathogenesis.
    Hairston BR; Davis MD; Pittelkow MR; Ahmed I
    Arch Dermatol; 2006 Nov; 142(11):1413-8. PubMed ID: 17116831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Vasculitis related to antineutrophil cytoplasmic antibodies to myelo peroxidase in a patient heterozygous for factor V Leiden mutation].
    Spuls PI; Nanninga PB; Mekkes JR
    Ned Tijdschr Geneeskd; 2000 Dec; 144(50):2430-1. PubMed ID: 11232541
    [No Abstract]   [Full Text] [Related]  

  • 13. Atypical presentation of livedo racemosa in a factor V Leiden heterozygous positive patient with Pseudomonas aeruginosa urosepsis.
    Johnston J; Noakes R; Davidson K
    Australas J Dermatol; 2017 Aug; 58(3):e144-e147. PubMed ID: 27858977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heterozygous prothrombin gene mutation associated with livedoid vasculopathy.
    Anavekar NS; Kelly R
    Australas J Dermatol; 2007 May; 48(2):120-3. PubMed ID: 17535202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Homozygous factor V Leiden mutation in a patient with traumatic leg ulceration.
    McLoone N; Lee B; Anderson J; McKenna K
    Clin Exp Dermatol; 2003 Nov; 28(6):608-9. PubMed ID: 14616826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Livedoid vasculopathy and hypercoagulability in a patient with primary Sjögren's syndrome.
    Cardoso R; Gonçalo M; Tellechea O; Maia R; Borges C; Silva JA; Figueiredo A
    Int J Dermatol; 2007 Apr; 46(4):431-4. PubMed ID: 17442092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Livedo reticularis and livedoid vasculitis responding to PUVA therapy.
    Choi HJ; Hann SK
    J Am Acad Dermatol; 1999 Feb; 40(2 Pt 1):204-7. PubMed ID: 10025746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Livedoid vasculopathy. Pathogenesis, diagnosis and treatment of cutaneous infarction].
    Goerge T
    Hautarzt; 2011 Aug; 62(8):627-34; quiz 635. PubMed ID: 21786003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Livedoid vasculiltis associated with a double heterozygous Factor V Leiden and prothrombin G20210A gene mutations.
    Khenifer S; Thomas L; Balme B; Dalle S
    Clin Exp Dermatol; 2009 Dec; 34(8):e811-3. PubMed ID: 19793098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Necrotic cutaneous vasculitic skin lesions: a case of atypical Henoch-Schönlein purpura in a child with heterozygosity for factor V Leiden.
    Dhanjal S; Saso A; Eleftheriou D; Laurent S
    BMJ Case Rep; 2017 May; 2017():. PubMed ID: 28536112
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.